|
Brand Name Manufacturers |
Danocrine by Sanofi Winthrop |
|
Generic Manufacturers |
Barr
Warner Chilcott |
|
Pharmacology |
FSH
and LH production inhibitor. Estrogen receptor antagonist.
Weak androgen. |
|
Delivery |
50,
100, 200mg oral capsules |
|
Typical dosage |
Pre-op 200-400mg/day |
|
Availability |
Approved by U.S. FDA |
|
Indications |
Endometriosis. Estrogen dependent fibrocystic breast disease.
Hereditary engorgement of blood vessels in males and females. |
|
Contraindications |
Hypersensitivity to light. Markedly impaired liver, kidney,
or heart function. |
|
Adverse reactions |
Gastrointestinal
Cholestatic
jaundice.
Skin
Acne.
Oily skin. Flushing. Sweating. Vaginal dryness.
Other
Blood
clotting disorders. Fluid retention. Increase of cholesterol
in blood. Increase of fluid pressure in skull. Liver pelisses
and benign tumors.
|
|
Comments |
None
|
| Additional
Info: |
Danocrine
Prescribing Information (PDF file on this site) |